Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
复制标题
瑞士学校儿童和青少年SARS-COV-2感染的血清阳性和免疫力:设计基于学校的前瞻性队列研究的设计。
DOI:
10.1007/s00038-020-01495-z
复制
发表时间:
2020-12
影响因子:
4.6
通讯作者:
Kriemler S
中科院分区:
文献类型:
--
作者:
Ulyte A;Radtke T;Abela IA;Haile SR;Braun J;Jung R;Berger C;Trkola A;Fehr J;Puhan MA;Kriemler S
This longitudinal cohort study aims to assess the extent and patterns of seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in school-attending children, and their parents and school personnel. It will examine risk factors for infection, the relationship between seropositivity and symptoms, and temporal persistence of antibodies. The study (Ciao Corona) will enroll a regionally representative, random sample of schools in the canton of Zurich, where 18% of the Swiss population live. Children aged 5–16 years, attending primary and secondary schools, and their parents and school personnel are invited. Venous blood and saliva samples are collected for serological testing in June/July 2020, in October/November 2020, and in March/April 2021. Bi-monthly questionnaires will cover SARS-CoV-2 symptoms and tests, health, preventive behavior, and lifestyle information. Hierarchical Bayesian logistic regression models will account for sensitivity and specificity of the serological tests in the analyses and complex sampling structure, i.e., clustering within classes and schools. This unique school-based study will allow describing temporal trends of immunity, evaluate effects of preventive measures and will inform goal-oriented policy decisions during subsequent outbreaks. Trial registration ClinicalTrials.gov Identifier: NCT04448717, registered June 26, 2020. https://clinicaltrials.gov/ct2/show/NCT04448717. The online version of this article (10.1007/s00038-020-01495-z) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
168.9
作者:
Pollan, Marina;Perez-Gomez, Beatriz;Yotti, Raquel
通讯作者:
Yotti, Raquel
DOI:
10.17269/s41997-020-00396-1
发表时间:
2020-08-07
影响因子:
4.3
作者:
Silverman, Michael;Sibbald, Robert;Stranges, Saverio
通讯作者:
Stranges, Saverio
影响因子:
15.8
作者:
Mossong, Joeel;Hens, Niel;Jit, Mark;Beutels, Philippe;Auranen, Kari;Mikolajczyk, Rafael;Massari, Marco;Salmaso, Stefania;Tomba, Gianpaolo Scalia;Wallinga, Jacco;Heijne, Janneke;Sadkowska-Todys, Malgorzata;Rosinska, Magdalena;Edmunds, W. John
通讯作者:
Edmunds, W. John
影响因子:
4.6
作者:
West EA;Anker D;Amati R;Richard A;Wisniak A;Butty A;Albanese E;Bochud M;Chiolero A;Crivelli L;Cullati S;d'Acremont V;Epure AM;Fehr J;Flahault A;Fornerod L;Frank I;Frei A;Michel G;Gonseth S;Guessous I;Imboden M;Kahlert CR;Kaufmann L;Kohler P;Mösli N;Paris D;Probst-Hensch N;Rodondi N;Stringhini S;Vermes T;Vollrath F;Puhan MA;Corona Immunitas Research Group
通讯作者:
Corona Immunitas Research Group
DOI:
10.1073/pnas.1821298116
发表时间:
2019-07-02
影响因子:
11.1
作者:
Litvinova, Maria;Liu, Quan-Hui;Ajelli, Marco
通讯作者:
Ajelli, Marco